Wei Y, Qian K, Le N, Wang L, et al. Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study. Ann Hematol 2024 Sep 7. doi: 10.1007/s00277-024-05972.
PMID: 39243311